Position history for DRIEHAUS CAPITAL MANAGEMENT LLC's holdings in BRIDGEBIO PHARMA INC
DRIEHAUS CAPITAL MANAGEMENT LLC holds 1.7M shares of BBIO (BRIDGEBIO PHARMA INC), worth $128.6M as of 2025-Q4. The position was increased (++1.1% shares). BBIO represents 0.9% of DRIEHAUS CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$128.6M
Current Shares
1.7M
Total Value Change
+$76.7M
Total Shares Change
+180,414
Other major holders of BBIO: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 1.7M |
+1.1% |
| $128.6M |
| 0.9% |
| $75.48 |
43 |
| 2025-Q3 | Decreased | 1.7M | -1.7% | $86.3M | 0.6% | $51.96 | 0 |
| 2025-Q2 | Increased | 1.7M | +12.7% | $73M | 0.6% | $44.86 | 47 |
| 2025-Q1 | New | 1.5M | - | $51.9M | 0.5% | $35.11 | 57 |